» Articles » PMID: 39209333

Long-term Outcomes of Smoker and Drinker with Oesophageal Squamous Cell Carcinoma After Oesophagectomy: a Large-scale Propensity Score Matching Analysis

Overview
Specialty Gastroenterology
Date 2024 Aug 29
PMID 39209333
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oesophageal squamous cell carcinoma (OSCC) poses a considerable health burden, particularly in regions such as East Asia. This study aims to investigate the long-term outcomes of OSCC patients who are smokers and drinkers.

Materials And Methods: In this retrospective analysis, data from Sichuan Cancer Hospital and Institute Esophageal Cancer Case Management Database between January 2010 and December 2017 were examined. Patients were categorised into different groups based on their smoking and alcohol consumption history: None, Smoker, Non-Smoker, Smoke-Only, Drinker, Non-Drinker, Drinker-Only, and Both. Survival outcomes were compared between the groups using Kaplan-Meier analysis and propensity score matching (PSM). The primary outcome was overall survival (OS), measured from surgery to death or last follow-up in April 2022.

Results: The OS median was 45.4 months for all patients after oesophagectomy. Smokers had a significantly lower median OS of 36.6 months compared with Non-Smokers with 66.2 months (p<0.001). Similarly, Drinkers had a lower median OS of 34.4 months compared with Non-Drinkers with 52.0 months (p<0.001). PSM analysis confirmed the significant differences in OS between Smokers and Non-Smokers (p=0.002) and between Drinkers and Non-Drinkers (p=0.002). Subgroup analyses showed no significant differences in OS between Group Another and Group Both, Group Smoker-Only and Group Drinker-Only, and Group Drinker-Only and Group Both. (figure 4) CONCLUSION: Smoking and drinking were associated with significantly reduced OS in patients. However, no significant differences were found between the subgroups of patients who only smoked, only drank, or engaged in both habits.

Citing Articles

Comparative analysis of manual vs. mechanical suturing techniques in esophagectomy: A propensity score‑matched study of long‑term outcomes.

Lu S, Li K, Jiang L, Xiong J, Liang S, Wang Z Oncol Lett. 2024; 29(1):51.

PMID: 39564370 PMC: 11574709. DOI: 10.3892/ol.2024.14797.

References
1.
Sun P, Chen C, Zhang F, Yang H, Bi X, An X . Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma. Onco Targets Ther. 2016; 9:4257-64. PMC: 4948733. DOI: 10.2147/OTT.S104182. View

2.
Tachimori Y, Ozawa S, Numasaki H, Matsubara H, Shinoda M, Toh Y . Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus. 2016; 13:1-7. PMC: 4698372. DOI: 10.1007/s10388-015-0515-3. View

3.
Jiang D, Song Q, Zhang F, Xu C, Li X, Zeng H . Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma. Cancer Genet. 2023; 278-279:1-8. DOI: 10.1016/j.cancergen.2023.07.004. View

4.
Shapiro J, van Lanschot J, Hulshof M, van Hagen P, van Berge Henegouwen M, Wijnhoven B . Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015; 16(9):1090-1098. DOI: 10.1016/S1470-2045(15)00040-6. View

5.
Huang Q, Luo K, Yang H, Wen J, Zhang S, Li J . Impact of alcohol consumption on survival in patients with esophageal carcinoma: a large cohort with long-term follow-up. Cancer Sci. 2014; 105(12):1638-46. PMC: 4317962. DOI: 10.1111/cas.12552. View